PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis
Weronika Wasyluk,1,2 Agnieszka Zwolak1 1Chair of Internal Medicine and Department of Internal Medicine in Nursing, Faculty of Health Sciences, Medical University of Lublin, Lublin, Poland; 2Doctoral School, Medical University of Lublin, Lublin, PolandCorrespondence: Weronika WasylukChair of Internal...
Guardado en:
Autores principales: | Wasyluk W, Zwolak A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b81ae721ef1448789419dd5e916dbe06 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
por: Amelia Barcellini, et al.
Publicado: (2021) -
Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
por: Desh Deepak Singh, et al.
Publicado: (2021) -
Temporal dynamics of base excision/single-strand break repair protein complex assembly/disassembly are modulated by the PARP/NAD+/SIRT6 axis
por: Christopher A. Koczor, et al.
Publicado: (2021) -
Update on Poly ADP-Ribose Polymerase Inhibitors in Ovarian Cancer With Non-BRCA Mutations
por: Qin Xu, et al.
Publicado: (2021) -
Screening of Key Genes of Sepsis and Septic Shock Using Bioinformatics Analysis
por: Zeng X, et al.
Publicado: (2021)